Studies have employed either genetic or proteomic approaches to demonstrate aberrant cancerous fibronectin expressions in various types of tumor cells and their experimental and clinical association with tumor malignancy, metastasis, or poor prognosis [18,21,22,23,24,25]. The gene discussed is FN1; the disease is neoplasm.